ParaZero Secures Second Israeli Defense Order for DefendAir Counter‑UAS System

PRZO
February 21, 2026

ParaZero Technologies Ltd. (Nasdaq: PRZO) announced on February 20 2026 that it has secured a second order for its DefendAir counter‑UAS system from a different branch of an Israeli defense entity. The order follows an earlier deployment announced on January 7 2026 and expands the company’s footprint within the Israeli defense community.

The DefendAir system is a multi‑layered counter‑UAS platform that uses a non‑kinetic net‑launching mechanism to neutralize hostile drones. ParaZero has reported 100 % interception success in live field trials against fast‑moving threats, including a 70 mph drone interception during internal testing. The new contract underscores growing confidence in the company’s technology and signals a continued shift from commercial drone safety to high‑value defense solutions.

The anti‑drone market is projected to reach $12.24 billion by 2032, a figure that falls within the range of recent industry forecasts. ParaZero’s growing order book positions it to capture a share of this expanding market, while its net‑launching approach differentiates it from kinetic and jamming competitors.

Financially, ParaZero’s revenue has risen year‑over‑year, with full‑year 2024 revenues of $932,154 versus $620,508 in 2023. The company remains in a net‑loss position, reporting a $11.05 million loss for 2024 and a $2.30 million loss for the first half of 2025, but the new defense order is expected to boost defense‑sector revenue and support the company’s long‑term growth strategy.

Investors have responded positively to the news, reflecting confidence in ParaZero’s expanding defense portfolio and the demonstrated effectiveness of its DefendAir system.

The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.